Physician profile
Abdur Rahim
NPI 1780675108
$7,942.62
in general payments reported to CMS, 2019-2025
33 companies · $1,042 in 2025
The $1,042 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,567 · 2020: $788 · 2021: $1,094 · 2022: $1,303 · 2023: $1,260 · 2024: $889 · 2025: $1,042.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,099 · Education: $92.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,098.62 |
| Education | $92.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $956.51 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $742.46 | 2019-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $733.45 | 2019-2025 | Lifevest |
| Pfizer INC. | $733.29 | 2019-2025 | |
| Glaxosmithkline, LLC. | $500.00 | 2019-2023 | |
| Astrazeneca Pharmaceuticals Lp | $431.25 | 2019-2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $373.61 | 2020-2025 | Jardiance |
| Abbott Laboratories | $348.42 | 2020-2022 | |
| Novo Nordisk INC | $310.11 | 2020-2025 | Wegovy, Ozempic |
| Merck Sharp & Dohme LLC | $276.31 | 2021-2025 | Verquvo |
| Boston Scientific Corporation | $266.58 | 2019-2025 | Watchman Flx, Watchman Access System, Varithena Administration Pack |
| Amgen INC. | $263.88 | 2019-2021 | |
| Lilly USA, LLC | $241.89 | 2019-2025 | Mounjaro, Zepbound |
| Astellas Pharma US INC | $216.41 | 2020-2021 | |
| Medtronic, INC. | $192.62 | 2021-2023 | Reveal Linq, Intellis Adaptivestim |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $175.69 | 2024-2025 | |
| Amarin Pharma, INC. | $170.19 | 2020-2021 | |
| Alnylam Pharmaceuticals INC. | $125.50 | 2024 | Amvuttra, Onpattro |
| Ucb, INC. | $125.00 | 2025 | Bimzelx |
| Actelion Pharmaceuticals US, INC. | $122.08 | 2020-2023 | Uptravi, Opsumit |
| Abiomed | $100.25 | 2019-2024 | Impella |
| Jazz Pharmaceuticals INC. | $100.00 | 2019 | |
| Kestra Medical Technology Services, INC. | $94.46 | 2023-2025 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $68.82 | 2023 | |
| Esperion Therapeutics, INC. | $66.62 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $47.07 | 2020-2023 | |
| Angiodynamics, INC. | $40.48 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.58 | 2025 | |
| Shire North American Group INC | $24.28 | 2019 | |
| Impulse Dynamics (USA) INC. | $21.19 | 2023 | Optimizer |
| Biotronik INC. | $20.63 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $17.01 | 2024 | Arcalyst |
| Allergan, INC. | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdur Rahim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.